Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Magellan Health (MGLN)

Magellan Health (MGLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Magellan Healthcare Releases Clinical Monograph: Appropriate Use of Psychotropic Drugs in Children and Adolescents

Magellan Healthcare, the behavioral and specialty healthcare segment of Magellan Health, Inc. , published its updated clinical monograph: Appropriate Use of Psychotropic Drugs in Children and Adolescents...

MGLN : 94.99 (unch)
Magellan Healthcare Launches New Digital Emotional Wellbeing Program

Magellan Healthcare , one of the nation’s leaders in behavioral health and a division of Magellan Health, Inc. (NASDAQ: MGLN), will soon launch a new Digital Emotional Wellbeing program that helps...

MGLN : 94.99 (unch)
Magellan Healthcare and DUOS to Offer Personal Assistant for Aging and Behavioral Health Support

Magellan Healthcare , the behavioral health division of Magellan Health, Inc. (NASDAQ: MGLN) today announced a program to connect older adults with companionship and care coordination to manage social...

MGLN : 94.99 (unch)
Magellan Health Responds to U.S. Surgeon General’s Call to Protect Youth Mental Health

Magellan Health, Inc. (NASDAQ: MGLN) today issued the following statement in response to the public health advisory by U.S. Surgeon General Vivek H. Murthy on the urgent need to address the mental health...

MGLN : 94.99 (unch)
Magellan Health Provides Free Consultation Services and Referrals to Local Community Resources to Individuals Impacted by Tornadoes in Kentucky and Several Other States

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will open a free 24-hour crisis line for individuals impacted by the severe tornadoes in Kentucky and several other states throughout the South...

MGLN : 94.99 (unch)
Magellan Health Provides Free Consultation Services and Referrals to Local Community Resources to Individuals after Flooding in Hawai’i

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will open a free 24-hour crisis line for individuals in Hawai’i who were affected by the recent flooding and its aftermath.

MGLN : 94.99 (unch)
Long Predicted Medicaid Specialty Drug Trend Finally Surpasses 50% of Pharmacy Spend in the Latest Magellan Rx Management Medicaid Pharmacy Trend Report

Magellan Rx Management , the full-service pharmacy benefits management division of Magellan Health, Inc. (NASDAQ: MGLN), released its sixth annual Medicaid Pharmacy Trend Report TM , the industry's...

MGLN : 94.99 (unch)
Magellan Health Announces Two New Appointments to Magellan Health Studio Advisory Council

Magellan Health, Inc . (NASDAQ: MGLN) today announced two new healthcare experts have been appointed to serve on the Magellan Health Studio Advisory Council . The Council consists of leaders who bring...

MGLN : 94.99 (unch)
Magellan Health: Q3 Earnings Snapshot

PHOENIX (AP) _ Magellan Health Inc. (MGLN) on Friday reported third-quarter earnings of $5.9 million.

MGLN : 94.99 (unch)
Magellan Health Reports Third Quarter 2021 Financial Results

Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the third quarter ended September 30, 2021, as summarized below:

MGLN : 94.99 (unch)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar